The global at-home testing kits market has witnessed significant growth in recent years. These testing kits provide consumers with the convenience of conducting various medical and diagnostic tests from the comfort of their homes. With advancements in technology and increased awareness about personal health monitoring, at-home testing kits have become a popular choice. They offer privacy, cost-effectiveness, and timely results, empowering individuals to take charge of their health and well-being. The market encompasses a wide range of testing kits for conditions such as fertility, infectious diseases, pregnancy, diabetes, and genetic testing.
Access Full Report @ https://www.databridgemarketresearch.com/reports/global-at-home-testing-kits-market
Data Bridge Market Research analyses that the At-Home Testing Kits Market is expected to reach USD 13,775.51 million by 2029 from USD 8,900.44 million in 2021 growing with a healthy CAGR of 6.1% in the forecast period of 2022 to 2029. The rise of e-commerce platforms and online marketplaces has made at-home testing kits more accessible to consumers worldwide. These platforms provide a convenient means of purchasing testing kits, expanding the market reach and customer base.
Key Findings of the Study
Increasing awareness and demand for preventive care is expected to drive the market's growth rate
The increasing awareness and demand for preventive care have driven the adoption of at-home testing kits. Detecting potential health issues early, individuals can seek timely medical intervention, make necessary lifestyle changes, and engage in preventive measures to mitigate the risks associated with certain diseases, leading to improved overall health outcomes.
Report Scope and Market Segmentation
Report Metric
|
Details
|
Forecast Period
|
2022-2029
|
Base Year
|
2021
|
Historic Years
|
2020 (Customizable to 2014-2019)
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
Segments Covered
|
Test Type (Pregnancy Test, HIV Test Kit, Diabetes, Infectious Diseases, Glucose Tests, Ovulation Predictor Test Kit, Drug Abuse Test Kit, and Others), Type (Cassette, Strip, Midstream, Test Panel, Dip Card, and Others), Age (Pediatric, Adult, and Geriatric), Sample Type (Urine, Blood, Saliva, and Other Sample Types), Usage (Disposable and Reusable), Distribution Channels (Retail Pharmacies, Drug Store, Supermarket/Hypermarket and Online Pharmacies)
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
Market Players Covered
|
Abbott (U.S.), Siemens Healthcare GmbH (Germany), F. Hoffmann-La Roche Ltd (Switzerland), BD (U.S.), Drägerwerk AG & Co. KGaA (Germany), LifeScan IP Holdings, LLC (U.S.), Ascensia Diabetes Care Holdings AG (Switzerland), Nectar Lifesciences Ltd. (India), ACON Laboratories, Inc. (U.S.), Quidel Corporation (U.S.), ARKRAY USA, Inc. (U.S.), BTNX INC. (Canada), Atomo Diagnostics (Australia), Eurofins Scientific (Luxembourg), Piramal Enterprises Ltd. (India), Bionime Corporation (Taiwan), Nova Biomedical (U.S.), Cardinal Health (U.S.), OraSure Technologies (U.S.), Biolytical Laboratories Inc. (Canada), Everlywell, Inc. (U.S.), SA Scientific Ltd. (U.K.), Clearblue (Switzerland), Biosynex (France), PRIMA Lab SA (Switzerland), MP Biomedicals (U.S.), Sterilab Services (Spain), Chembio Diagnostics, Inc. (U.S.), BioSure (U.K.), Selfdiagnostics OU (Estonia), among others
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis:
The at-home testing kits market is segmented on the basis of test type, type, age, and sample type, usage, and distribution channels.
- On the basis of test type, the global at-home testing kits market is segmented into pregnancy test, HIV test kit, diabetes, infectious diseases, glucose tests, ovulation predictor test kit, drug abuse test kit and other test types. In 2022, glucose test type is dominating the global At-Home Testing Kits market with a CAGR of 6.2% in the forecast period of 2022 to 2029 due to measure glucose levels in blood or urine to monitor and manage conditionmeasuringas diabetes or hypoglycaemia.
In 2022, glucose test type is dominating the test type segment of the global at-home testing kits market
In 2022, glucose test type is dominating the global at-home testing kits market owing to monitoring and treatment conditions such as diabetes or hypoglycemia, glucose levels in the blood or urine are measured with a CAGR of 6.2% in the forecast period of 2022 to 2029
- 根據類型，全球家用檢測試劑盒市場分為盒式、條式、中游式、測試面板式、浸卡式和其他形式類型。 2022 年，由於試紙條易於使用、經濟高效且適用於各種測試應用，它將在家用測試套件市場佔據主導地位，預測期內（2022 年至 2029 年）的複合年增長率為 6.5%。條狀格式因其簡單性和可靠性而被廣泛採用，成為許多消費者和醫療保健專業人士的首選。
- 根據年齡，全球家用檢測試劑盒市場分為兒童、成人和老年人。 2022 年，與兒科和老年族群相比，成年人群的人口規模更大、醫療保健需求更高，因此他們將在家用檢測試劑盒市場佔據主導地位，預測期內（2022 年至 2029 年）的複合年增長率為 6.4%。成年人更有可能使用家用檢測試劑進行各種健康監測。
- 根據樣本類型，全球家用檢測試劑盒市場分為尿液、血液、唾液和其他樣本類型。 2022 年，血型將佔據家用檢測試劑盒市場的主導地位，由於其易於收集、非侵入性以及能夠提供有關各種健康狀況的有價值信息，預測期內（2022 年至 2029 年）的複合年增長率為 6.3%。
- 根據用途，全球家用檢測試劑盒市場分為一次性和可重複使用兩類。 2022 年，一次性產品憑藉其便利性、清潔度和簡單性，將在家用檢測試劑盒市場佔據主導地位，預測期內（2022 年至 2029 年）的複合年增長率為 5.8%。為了提供個人準確、輕鬆的檢測，一次性試劑盒不需要清潔或消毒。
2022 年，一次性產品將佔據家用檢測試劑盒市場的主導地位
2022 年，一次性產品憑藉其便利性、衛生性和易用性，在家用檢測試劑盒市場佔據主導地位。一次性試劑盒無需清潔或消毒，確保個人能夠進行準確、輕鬆的檢測，預測期內（2022 年至 2029 年）的複合年增長率為 5.8%
- 根據分銷管道，全球家用檢測試劑盒市場分為零售藥局、藥局、超市/大賣場和線上藥局。 2022 年，零售藥局將主導家用檢測試劑盒市場，由於其檢測試劑盒種類繁多、員工知識淵博，並可直接聯繫醫療保健專業人員，預測期內的複合年增長率為 6.0%，因此成為尋求家用檢測解決方案的消費者的首選。
主要參與者
Data Bridge Market Research 認為以下公司是家庭檢測試劑盒 市場的主要參與者，它們是雅培（美國）、西門子醫療有限公司（德國）、F. Hoffmann-La Roche Ltd（瑞士）、BD（美國）、Drägerwerk AG & Co. KGaA（德國）、LifeScan IP Holdings, LLC（美國）、Ascensia DiAscone, Cares Holdings（瑞士）。 Inc.（美國）、Quidel Corporation（美國）
市場發展
- 據 ACON Laboratories, Inc. 稱，2021 年，美國食品藥物管理局批准了 Flowflex COVID-19 抗原家用檢測試劑盒用於緊急情況。這將有助於該公司擴大產品線和全球市場份額。
- 2021 年，Viatris 和 Atomo Diagnostics 同意協助 Unitaid 完成其使命，即提高中低收入國家 (LMIC) 的愛滋病毒自我檢測的可用性。國際藥品採購機制的擴展計畫將資助分發多達一百萬個愛滋病毒自檢試劑盒，並承諾讓 135 個國家能夠進行檢測。
- 2020 年，OraSure Technologies, Inc. 與美國生物醫學高級研究與發展局 (BARDA) 和伯利恆再次合作，開發一種體外（實驗室）診斷方法，用於檢測口腔液中的 SARS-CoV-2 病毒抗體。透過此次合作，該公司將針對當前的疫情開發先進的快速診斷測試並擴大業務。
區域分析
從地理上看，家用檢測試劑盒市場報告涵蓋的國家有：北美洲的美國、加拿大和墨西哥，歐洲的德國、法國、英國、荷蘭、瑞士、比利時、俄羅斯、義大利、西班牙、土耳其，歐洲其他地區，中國、日本、印度、韓國、新加坡、馬來西亞、澳洲、泰國、印尼、菲律賓，亞太地區（APAC）的其他亞太地區（APAC），沙烏地阿拉伯、阿聯酋、南非、埃及、以色列，中東和非洲（MEA）的其他中東和非洲（MEA），南美洲的巴西、阿根廷和南美洲其他地區。
根據 Data Bridge 市場研究分析：
2022-2029 年預測期內，北美是家用檢測試劑盒市場的主導地區
北美在全球家用檢測試劑盒市場的主導地位可歸因於多種因素。該地區擁有強大的醫療保健基礎設施和高額的醫療保健支出，這促進了家庭檢測試劑盒等先進醫療保健解決方案的採用。此外，人們對於在家中進行檢測對於早期發現疾病的好處的認識不斷提高，這也促進了市場的成長。這些因素加上有利的監管環境，使北美成為家庭檢測試劑盒的領先市場。
有關家用檢測試劑盒市場 報告的更多詳細信息，請點擊此處 - https://www.databridgemarketresearch.com/reports/global-at-home-testing-kits-market
